Repligen has announced that it acquired the assets of BioFlash Partners for $1.8 million, which includes a technology platform for the production of pre-packed, ?plug and play? chromatography columns.
Repligen has announced that it acquired the assets of BioFlash Partners for $1.8 million, which includes a technology platform for the production of pre-packed, ‘plug and play’ chromatography columns.
According to the company this technology enables economical production of chromatography columns in a format that is ready for use in the production of a broad range of biopharmaceuticals including monoclonal antibodies, vaccines and recombinant proteins.
“We are very pleased to have acquired the BioFlash platform, a technology which will enable us to meet the growing market need for flexible, pre-packed chromatography products,” said Walter C. Herlihy, president and CEO of Repligen in a statement.
The company reports that products based on the acquired technology will be offered in a range of column diameters and bed heights and can be prepacked with commercially available chromatography resins including immobilized Protein A.
The terms of the acquisition also include a contingent milestone and royalties based on product sales.
For more information visit www.repligen.com
Advanced LC–MS Analysis for PFAS Analysis in Eggs
October 11th 2024The European Commission's regulation on maximum levels for certain contaminants in food highlights the need for precise and reliable methods to quantify per- and polyfluoroalkyl substances (PFAS) in various food matrices. This article discusses development and validation of a robust method for analyzing 21 PFAS compounds in chicken eggs using solid-phase extraction (SPE) and liquid chromatography–mass spectrometry (LC–MS).
Characterizing Cooked Cheese Flavor with Gas Chromatography
October 11th 2024A joint study by the Department of Food and Nutritional Sciences at the University of Reading and Synergy Flavours aimed to identify volatiles that contribute to the aroma of cooked cheese, including the role of fat content in development during cooking.
Deep Learning Framework for Peak Detection at the Intact Level of Therapeutic Proteins
October 11th 2024Although automated peak detection functionalities are available in commercially accessible software, utilizing visual inspection and manual adjustments to achieve optimal true positive rates is often necessary. A recent study conducted by the Department of Chemical Engineering at the Indian Institute of Technology (Delhi, India) used liquid chromatography-mass spectrometry (LC–MS) to distinguish hetero-variants (glycoforms) resulting in a monoclonal antibody (mAb) able to be characterized, revealing discernible peaks at the intact level. LCGC International spoke to Anurag Rathore, corresponding author for the article, about his department’s findings.